Harrison R. Davis, Ph.D. - Publications

Affiliations: 
2003 University of Arkansas, Little Rock, AR 
Area:
Guidance and Counseling Education, Higher Education, Ethnic and Racial Studies, Black Studies

112 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Grismer LL, Wood PL, Anuar S, Grismer MS, Quah ESH, Murdoch ML, Muin MA, Davis HR, Aguilar C, Klabacka R, Cobos AJ, Aowphol A, Sites JW. Two new Bent-toed Geckos of the Cyrtodactylus pulchellus complex from Peninsular Malaysia and multiple instances of convergent adaptation to limestone forest ecosystems Zootaxa. 4105: 401-429. DOI: 10.11646/zootaxa.4105.5.1  0.01
2016 Davis HR, Grismer LL, Klabacka RL, Muin MA, Quah ESH, Anuar S, Wood PL, Sites JW. The phylogenetic relationships of a new Stream Toad of the genus Ansonia Stoliczka, 1870 (Anura: Bufonidae) from a montane region in Peninsular Malaysia Zootaxa. 4103: 137-153. DOI: 10.11646/zootaxa.4103.2.4  0.01
2016 Lee Grismer L, Wood PL, Anuar S, Davis HR, Cobos AJ, Murdoch ML. A new species of karst forest Bent-Toed Gecko (genus Cyrtodactylus Gray) not yet threatened by foreign cement companies and a summary of Peninsular Malaysia's endemic karst forest herpetofauna and the need for its conservation Zootaxa. 4061: 1-17. DOI: 10.11646/zootaxa.4061.1.1  0.01
2015 Nanda V, Downing KP, Ye J, Xiao S, Kojima Y, Spin JM, DiRenzo DM, Nead K, Connolly AJ, Dandona S, Perisic L, Hedin U, Maegdefessel L, Dalman J, Guo L, ... Davis HR, et al. CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels. Circulation Research. PMID 26596284 DOI: 10.1161/Circresaha.115.307906  0.01
2015 Yahagi K, Kolodgie FD, Otsuka F, Finn AV, Davis HR, Joner M, Virmani R. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nature Reviews. Cardiology. PMID 26503410 DOI: 10.1038/nrcardio.2015.164  0.01
2015 Guan HP, Yang X, Lu K, Wang SP, Castro-Perez JM, Previs S, Wright M, Shah V, Herath K, Xie D, Szeto D, Forrest G, Xiao JC, Palyha O, Sun LP, ... Davis HR, et al. Glucagon receptor antagonism induces increased cholesterol absorption. Journal of Lipid Research. PMID 26373568 DOI: 10.1194/Jlr.M060897  0.01
2015 Otsuka F, Kramer MC, Woudstra P, Yahagi K, Ladich E, Finn AV, de Winter RJ, Kolodgie FD, Wight TN, Davis HR, Joner M, Virmani R. Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study. Atherosclerosis. 241: 772-82. PMID 26058741 DOI: 10.1016/j.atherosclerosis.2015.05.011  0.01
2015 Yahagi K, Davis HR, Arbustini E, Virmani R. Sex differences in coronary artery disease: pathological observations. Atherosclerosis. 239: 260-7. PMID 25634157 DOI: 10.1016/j.atherosclerosis.2015.01.017  0.01
2015 Yahagi K, Davis HR, Joner M, Virmani R. Atherosclerosis, introduction and pathophysiology Pathophysiology and Pharmacotherapy of Cardiovascular Disease. 527-546. DOI: 10.1007/978-3-319-15961-4_25  0.01
2015 Davis HR. Hypericum: Botanical sources, medical properties and health effects Hypericum: Botanical Sources, Medical Properties and Health Effects. 1-202.  0.01
2014 Maehara A, van Geuns RJ, Louvard Y, Müller R, Grube E, Morice MC, Davis HR, Kaplan AV, Onuma Y, Serruys PW, Mintz GS. Serial intravascular ultrasound observations from the Tryton first-in-man study. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. 10: 475-83. PMID 25138185 DOI: 10.4244/EIJV10I4A81  0.01
2014 Foody JM, Toth PP, Tershakovec AM, Musliner T, Tomassini JE, Lowe RS, Neff DR, Davis HR. Efficacy and safety of ezetimibe plus atorvastatin therapy Clinical Lipidology. 9: 441-470. DOI: 10.2217/clp.14.36  0.01
2013 Hentze H, Jensen KK, Chia SM, Johns DG, Shaw RJ, Davis HR, Shih SJ, Wong KK. Inverse relationship between LDL cholesterol and PCSK9 plasma levels in dyslipidemic cynomolgus monkeys: effects of LDL lowering by ezetimibe in the absence of statins. Atherosclerosis. 231: 84-90. PMID 24125416 DOI: 10.1016/j.atherosclerosis.2013.08.028  0.01
2011 Davis HR, Tershakovec AM, Tomassini JE, Musliner T. Intestinal sterol transporters and cholesterol absorption inhibition. Current Opinion in Lipidology. 22: 467-78. PMID 22101558 DOI: 10.1097/MOL.0b013e32834c7c28  0.01
2011 Davis HR, Lowe RS, Neff DR. Effects of ezetimibe on atherosclerosis in preclinical models. Atherosclerosis. 215: 266-78. PMID 21397230 DOI: 10.1016/j.atherosclerosis.2011.02.010  0.01
2011 Ason B, Tep S, Davis HR, Xu Y, Tetzloff G, Galinski B, Soriano F, Dubinina N, Zhu L, Stefanni A, Wong KK, Tadin-Strapps M, Bartz SR, Hubbard B, Ranalletta M, et al. Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9. Journal of Lipid Research. 52: 679-87. PMID 21262787 DOI: 10.1194/Jlr.M013664  0.01
2011 Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR, Couture P. Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. Journal of Lipid Research. 52: 558-65. PMID 21123766 DOI: 10.1194/Jlr.M011080  0.01
2010 Vassileva G, Hu W, Hoos L, Tetzloff G, Yang S, Liu L, Kang L, Davis HR, Hedrick JA, Lan H, Kowalski T, Gustafson EL. Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice. The Journal of Endocrinology. 205: 225-32. PMID 20354075 DOI: 10.1677/JOE-10-0009  0.01
2010 Lan H, Pang L, Smith MM, Levitan D, Ding W, Liu L, Shan L, Shah VV, Laverty M, Arreaza G, Zhang Q, Murgolo NJ, Hernandez M, Greene JR, Gustafson EL, ... ... Davis HR, et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cells. Journal of Cellular Physiology. 224: 273-81. PMID 20333646 DOI: 10.1002/Jcp.22130  0.01
2009 Halleck M, Davis HR, Kirschmeier P, Levitan D, Snyder RD, Treinen K, Macdonald JS. An assessment of the carcinogenic potential of ezetimibe using nonclinical data in a weight-of-evidence approach. Toxicology. 258: 116-30. PMID 19428931 DOI: 10.1016/j.tox.2009.01.017  0.01
2009 Davis HR, Altmann SW. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter. Biochimica Et Biophysica Acta. 1791: 679-83. PMID 19272334 DOI: 10.1016/j.bbalip.2009.01.002  0.01
2009 Woźniak PR, Vestrand WT, Panaitescu AD, Wren JA, Davis HR, White RR. GAMMA-ray burst at the extreme: "The naked-eye burst" GRB 080319B Astrophysical Journal. 691: 495-502. DOI: 10.1088/0004-637X/691/1/495  0.01
2009 Kantak AA, Hrenya MC, Davis HR. Initial rates of aggregation for dilute, granular flows of wet particles Physics of Fluids. 21. DOI: 10.1063/1.3070830  0.01
2008 Lan H, Hoos LM, Liu L, Tetzloff G, Hu W, Abbondanzo SJ, Vassileva G, Gustafson EL, Hedrick JA, Davis HR. Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic disease. Diabetes. 57: 2999-3006. PMID 18678612 DOI: 10.2337/db08-0596  0.01
2008 Davis HR, Basso F, Hoos LM, Tetzloff G, Lally SM, Altmann SW. Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1). Atherosclerosis. Supplements. 9: 77-81. PMID 18585981 DOI: 10.1016/j.atherosclerosissup.2008.05.008  0.01
2008 Davis HR, Murgolo NJ, Graziano MP. Simvastatin with or without ezetimibe in familial [6] New England Journal of Medicine. 359: 531.  0.01
2007 Davis HR, Veltri EP. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. Journal of Atherosclerosis and Thrombosis. 14: 99-108. PMID 17587760 DOI: JST.JSTAGE/jat/14.99  0.01
2007 Davis HR, Hoos LM, Tetzloff G, Maguire M, Zhu LJ, Graziano MP, Altmann SW. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 841-9. PMID 17218600 DOI: 10.1161/01.ATV.0000257627.40486.46  0.01
2007 Hawes BE, O'neill KA, Yao X, Crona JH, Davis HR, Graziano MP, Altmann SW. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs. Molecular Pharmacology. 71: 19-29. PMID 17005902 DOI: 10.1124/mol.106.027896  0.01
2006 Vassileva G, Golovko A, Markowitz L, Abbondanzo SJ, Zeng M, Yang S, Hoos L, Tetzloff G, Levitan D, Murgolo NJ, Keane K, Davis HR, Hedrick J, Gustafson EL. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. The Biochemical Journal. 398: 423-30. PMID 16724960 DOI: 10.1042/BJ20060537  0.01
2005 Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR, Dean DC, Detmers PA, Graziano MP, Hughes M, Macintyre DE, Ogawa A, O'neill KA, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proceedings of the National Academy of Sciences of the United States of America. 102: 8132-7. PMID 15928087 DOI: 10.1073/pnas.0500269102  0.01
2005 Aoki J, Serruys PW, Van Beusekom H, Ong ATL, McFadden EP, Sianos G, Van Der Giessen WJ, Regar E, De Feyter PJ, Davis HR, Rowland S, Kutryk MJB. Endothelial progenitor cell capture by stents coated with antibody against CD34: The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First in Man) registry Journal of the American College of Cardiology. 45: 1574-1579. PMID 15893169 DOI: 10.1016/j.jacc.2005.01.048  0.01
2005 Iyer SP, Yao X, Crona JH, Hoos LM, Tetzloff G, Davis HR, Graziano MP, Altmann SW. Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochimica Et Biophysica Acta. 1722: 282-92. PMID 15777641 DOI: 10.1016/j.bbagen.2004.12.021  0.01
2004 Davis HR, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam MH, Lund EG, Detmers PA, Graziano MP, Altmann SW. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. The Journal of Biological Chemistry. 279: 33586-92. PMID 15173162 DOI: 10.1074/jbc.M405817200  0.01
2004 Altmann SW, Davis HR, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science (New York, N.Y.). 303: 1201-4. PMID 14976318 DOI: 10.1126/science.1093131  0.01
2003 Van Heek M, Farley C, Compton DS, Hoos LM, Smith-Torhan A, Davis HR. Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats British Journal of Pharmacology. 138: 1459-1464. PMID 12721101 DOI: 10.1038/sj.bjp.0705187  0.01
2003 Elner SG, Elner VM, Kindzelskii AL, Horino K, Davis HR, Todd RF, Glagov S, Petty HR. Human RPE cell lysis of extracellular matrix: functional urokinase plasminogen activator receptor (uPAR), collagenase and elastase. Experimental Eye Research. 76: 585-95. PMID 12697422 DOI: 10.1016/S0014-4835(03)00028-9  0.01
2002 Altmann SW, Davis HR, Yao X, Laverty M, Compton DS, Zhu LJ, Crona JH, Caplen MA, Hoos LM, Tetzloff G, Priestley T, Burnett DA, Strader CD, Graziano MP. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochimica Et Biophysica Acta. 1580: 77-93. PMID 11923102 DOI: 10.1016/S1388-1981(01)00190-1  0.01
2002 Burnett DA, Caplen MA, Browne ME, Zhau H, Altmann SW, Davis HR, Clader JW. Synthesis of fluorescent biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors. Bioorganic & Medicinal Chemistry Letters. 12: 315-8. PMID 11814786 DOI: 10.1016/S0960-894X(01)00752-1  0.01
2001 Davis HR, Compton DS, Hoos L, Tetzloff G. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in apoE knockout mice Arteriosclerosis, Thrombosis, and Vascular Biology. 21: 2032-2038. PMID 11742881  0.01
2001 Van Heek M, Farley C, Compton DS, Hoos L, Davis HR. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function British Journal of Pharmacology. 134: 409-417. PMID 11564660  0.01
2001 Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA, Tigue ZD, Chisum HJ, Moses P, Pierce K, Lord C, Lincoln AJ, Pizzo S, Schreibman L, Haas RH, Akshoomoff NA, et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology. 57: 245-54. PMID 11468308 DOI: 10.1212/Wnl.57.2.245  0.01
2001 Van Heek M, Austin TM, Farley C, Cook JA, Tetzloff GG, Davis HR. Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters Diabetes. 50: 1330-1335. PMID 11375333  0.01
2001 Van Heek M, Compton DS, Davis HR. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys European Journal of Pharmacology. 415: 79-84. PMID 11245855 DOI: 10.1016/S0014-2999(01)00825-1  0.01
2001 Burnett DA, Davis HR. Chapter 6. Recent advances in the science and treatment of atherosclerosis Annual Reports in Medicinal Chemistry. 36: 57-66.  0.01
2000 Knook AH, Wardeh AJ, Rensing BJ, Foley DP, Van Der Giessen WJ, Van Den Brand M, De Feyter PJ, Davis HR, Becker GJ, Serruys PW. Low rates of clinical restenosis with the new flexible stainless steel tube intracoronary stent: the R Stent. A six-month safety and feasibility study. International Journal of Cardiovascular Interventions. 3: 91-95. PMID 12470375 DOI: 10.1080/14628840050516172  0.01
2000 Van Heek M, Farley C, Compton DS, Hoos L, Alton KB, Sybertz EJ, Davis HR. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663 British Journal of Pharmacology. 129: 1748-1754. PMID 10780982  0.01
2000 Dolny DG, Collins MG, Germann SL, Phipps WT, Davis HR. Comparison of Power Output Generated on the Wingate Cycle Ergometer and on a New, Closed- Chain Lower-Extremity Dynamometer Journal of Strength and Conditioning Research. 14: 87-91.  0.01
2000 Rosenblum SB, Huynh T, Afonso A, Davis HR. Synthesis of 3-arylpropenyl, 3-arylpropynyl and 3-arylpropyl 2-azetidinones as cholesterol absorption inhibitors: Application of the palladium-catalyzed arylation of alkenes and alkynes Tetrahedron. 56: 5735-5742.  0.01
1998 Vaccaro WD, Sher R, Davis HR. Carboxy-substitutes 2-azetidinones as cholesterol absorption inhibitors Bioorganic and Medicinal Chemistry Letters. 8: 319-322. PMID 9871677 DOI: 10.1016/S0960-894X(98)00009-2  0.01
1998 Vaccaro WD, Davis HR. Sugar-substitutes 2-azetidinone cholesterol absorption inhibitors: Enhanced potency by modification of the sugar Bioorganic and Medicinal Chemistry Letters. 8: 313-318. PMID 9871676 DOI: 10.1016/S0960-894X(98)00008-0  0.01
1998 Vaccaro WD, Sher R, Davis HR. Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors Bioorganic and Medicinal Chemistry Letters. 8: 35-40. PMID 9871624 DOI: 10.1016/S0960-894X(97)10185-8  0.01
1998 Vaccaro WD, Sher R, Davis HR. 2-Azetidinone cholesterol absorption inhibitors: Increased potency by substitution of the C-4 phenyl ring Bioorganic and Medicinal Chemistry. 6: 1429-1437. PMID 9801814 DOI: 10.1016/S0968-0896(98)00073-X  0.01
1998 Davis HR, Mullins DE, Pines JM, Hoos LM, France CF, Compton DS, Graziano MP, Sybertz EJ, Strader CD, Van Heek M. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats. Obesity Research. 6: 147-56. PMID 9545022  0.01
1998 Rosenblum SB, Huynh T, Afonso A, Davis HR, Yumibe N, Clader JW, Burnett DA. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. Journal of Medicinal Chemistry. 41: 973-80. PMID 9526571 DOI: 10.1021/jm970701f  0.01
1997 Van Heek M, France CF, Compton DS, McLeod RL, Yumibe NP, Alton KB, Sybertz EJ, Davis HR. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461 Journal of Pharmacology and Experimental Therapeutics. 283: 157-163. PMID 9336320  0.01
1997 Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis HR. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. The Journal of Clinical Investigation. 99: 385-90. PMID 9022070 DOI: 10.1172/JCI119171  0.01
1996 Davis HR, Mitrius JV. Recent legislation on genetics and insurance Jurimetrics. 37: 69-82. PMID 11658097  0.01
1996 Clader JW, Burnett DA, Caplen MA, Domalski MS, Dugar S, Vaccaro W, Sher R, Browne ME, Zhao H, Burrier RE, Salisbury B, Davis HR. 2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus. Journal of Medicinal Chemistry. 39: 3684-93. PMID 8809157 DOI: 10.1021/jm960405n  0.01
1996 Kirkup MP, Rizvi R, Shankar BB, Dugar S, Clader JW, McCombie SW, Lin SI, Yumibe N, Huie K, Van Heek M, Compton DS, Davis HR, McPhail AT. (-)-SCH 57939: Synthesis and pharmacological properties of a potent, metabolically stable cholesterol absorption inhibitor Bioorganic and Medicinal Chemistry Letters. 6: 2069-2072. DOI: 10.1016/0960-894X(96)00365-4  0.01
1996 Dugar S, Yumibe N, Clader JW, Vizziano M, Huie K, Van Heek M, Compton DS, Davis HR. Metabolism and structure activity data based drug design: Discovery of (-) SCH 53079 an analog of the potent cholesterol absorption inhibitor (-) SCH 48461 Bioorganic and Medicinal Chemistry Letters. 6: 1271-1274. DOI: 10.1016/0960-894X(96)00214-4  0.01
1996 Lyon RT, Davis HR, Runyon-Hass A, Glagov S, Zarins CK. Does Relief of Critical Arterial Stenosis Accelerate Distal Atherosclerosis? Vascular Surgery. 30: 191-200.  0.01
1995 Dugar S, Davis HR, Burrier RE, Salisbury BG. Amides of piperidine, morpholine and piperazine substituted 1-phenylethylamines: Inhibitors of acylCoA:cholesterol acyltransferase (ACAT) activity in vitro and in vivo Bioorganic and Medicinal Chemistry. 3: 1231-1236. PMID 8564414 DOI: 10.1016/0968-0896(95)00092-U  0.01
1995 Burrier RE, Smith AA, McGregor DG, Hoos LM, Zilli DL, Davis HR. The effect of acyl CoA: Cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine Journal of Pharmacology and Experimental Therapeutics. 272: 156-163. PMID 7815329  0.01
1995 Salisbury BG, Davis HR, Burrier RE, Burnett DA, Bowkow G, Caplen MA, Clemmons AL, Compton DS, Hoos LM, McGregor DG. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis. 115: 45-63. PMID 7669087 DOI: 10.1016/0021-9150(94)05499-9  0.01
1995 Dugar S, Kirkup MP, Clader JW, Lin SI, Rizvi R, Snow ME, Davis HR, McCombie SW. Gamma-lactams and related compounds as cholesterol absorption inhibitors: homologs of the beta-lactam cholesterol absorption inhibitor SCH 484611 Bioorganic and Medicinal Chemistry Letters. 5: 2947-2952. DOI: 10.1016/0960-894X(95)00516-6  0.01
1995 Clader JW, Berger JG, Burrier RE, Davis HR, Domalski M, Dugar S, Kogan TP, Salisbury B, Vaccaro W. Substituted (1,2-diarylethyl)amide acyl-CoA:cholesterol acyltransferase inhibitors: Effect of polar groups on in vitro and in vivo activity Journal of Medicinal Chemistry. 38: 1600-1607.  0.01
1994 Burrier RE, Deren S, McGregor DG, Hoos LM, Smith AA, Davis HR. Demonstration of a direct effect on hepatic acyl CoA:cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster Biochemical Pharmacology. 47: 1545-1551. PMID 8185666 DOI: 10.1016/0006-2952(94)90530-4  0.01
1994 Burnett DA, Caplen MA, Davis HR, Burrier RE, Clader JW. 2-Azetidinones as inhibitors of cholesterol absorption. Journal of Medicinal Chemistry. 37: 1733-6. PMID 8021912 DOI: 10.1021/jm00038a001  0.01
1994 Mullins DE, Hamud F, Reim R, Davis HR. Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl- 5-chlorobenzene sulfonylphthalimide Arteriosclerosis and Thrombosis. 14: 1047-1055. PMID 8018659  0.01
1994 Fostiak RJ, Davis HR. Electrical features of the rocky mountain pumped-storage project Ieee Transactions On Energy Conversion. 9: 206-213. DOI: 10.1109/60.282494  0.01
1993 Watkins RW, Pula K, Cook J, Hoos L, McLeod R, Prioli NA, Davis HR. NG-nitro-L-arginine methyl ester does not affect balloon catheter-induced intimal hyperplasia in rats. Biochemical and Biophysical Research Communications. 197: 304-9. PMID 7504485 DOI: 10.1006/bbrc.1993.2476  0.01
1993 Davis HR, Byers CW. The role of bottom currents and pelagic settling in the deposition of shale in an oxygen-stratified basin: case study of the Mowry Shale (Cretaceous) of Wyoming Geological Association of Canada Special Paper. 39: 177-188.  0.01
1992 Stanley DJ, Warne AG, Davis HR, Bernasconi MP, Zhongyuan Chen. The late Quaternary north-central Nile Delta from Manzala to Burullus Lagoons, Egypt National Geographic Research &Amp; Exploration. 8: 22-51.  0.01
1991 Elner SG, Elner VM, Pavilack MA, Davis HR, Cornicelli JA, Yue BYJT. Human and monkey corneal endothelium expression of low-density lipoprotein receptors American Journal of Ophthalmology. 111: 84-91. PMID 1985497  0.01
1989 Rich S, Miller JF, Charous S, Davis HR, Shanks P, Glagov S, Lands WEM. Development of atherosclerosis in genetically hyperlipidemic rabbits during chronic fish-oil ingestion Arteriosclerosis. 9: 189-194. PMID 2923575 DOI: 10.1161/01.ATV.9.2.189  0.01
1989 Lichtor T, Davis HR, Vesselinovitch D, Wissler RW, Mullan S. Suppression of atherogenesis by nifedipine in the cholesterol-fed rhesus monkey. Applied Pathology. 7: 8-18. PMID 2706143  0.01
1989 Davis HR, Byers CW, Pratt LM. Depositional mechanisms and organic matter in Mowry Shale (Cretaceous), Wyoming American Association of Petroleum Geologists Bulletin. 73: 1103-1116. DOI: 10.1306/44B4A546-170A-11D7-8645000102C1865D  0.01
1989 Davis HR, Byers CW. Shelf sandstones in the Mowry Shale: evidence for deposition during Cretaceous sea level falls Journal of Sedimentary Petrology. 59: 548-560. DOI: 10.1306/212F8FE4-2B24-11D7-8648000102C1865D  0.01
1988 Cozzi PJ, Lyon RT, Davis HR, Sylora J, Glagov S, Zarins CK. Aortic wall metabolism in relation to susceptibility and resistance to experimental atherosclerosis Journal of Vascular Surgery. 7: 706-714. PMID 3367436 DOI: 10.1016/0741-5214(88)90017-1  0.01
1988 Davis HR, Byers CW, Dean WE. Pyrite formation in the Lower Cretaceous Mowry Shale: effect of organic matter type and reactive iron content American Journal of Science. 288: 873-890.  0.01
1987 Lyon RT, Runyon-Hass A, Davis HR, Glagov S, Zarins CK. Protection from atherosclerotic lesion formation by reduction of artery wall motion Journal of Vascular Surgery. 5: 59-67. PMID 3795393 DOI: 10.1016/0741-5214(87)90195-9  0.01
1987 Grande J, Davis HR, Bates S, Mathews MB, Glagov S. Effect of an elastin growth substrate on cholesteryl ester synthesis and foam cell formation by cultured aortic smooth muscle cells Atherosclerosis. 68: 87-93. PMID 3689485 DOI: 10.1016/0021-9150(87)90097-9  0.01
1987 Lichtor T, Davis HR, Johns L, Vesselinovitch D, Wissler RW, Mullan S. The sympathetic nervous system and atherosclerosis. Journal of Neurosurgery. 67: 906-14. PMID 3681430 DOI: 10.3171/Jns.1987.67.6.0906  0.01
1987 Davis HR, Bridenstine RT, Vesselinovitch D, Wissler RW. Fish oil inhibits development of atherosclerosis in rhesus monkeys. Arteriosclerosis (Dallas, Tex.). 7: 441-9. PMID 3675303  0.01
1987 Yue BYJT, Elner VM, Elner SG, Davis HR. Lysosomal enzyme activities in cultured trabecularmeshwork cells Experimental Eye Research. 44. PMID 3653279 DOI: 10.1016/S0014-4835(87)80051-9  0.01
1986 Davis HR, Glagov S. Lectin binding to distinguish cell types in fixed atherosclerotic arteries Atherosclerosis. 61: 193-203. PMID 3533093 DOI: 10.1016/0021-9150(86)90138-3  0.01
1985 Davis HR, Glagov S, Zarins CK. Role of acid lipase in cholesteryl ester accumulation during atherogenesis. Correlation of enzyme activity with acid lipase-containing macrophages in rabbit and human lesions Atherosclerosis. 55: 205-215. PMID 4004991 DOI: 10.1016/0021-9150(85)90099-1  0.01
1985 Wissler RW, Vesselinovitch D, Davis HR, Lambert PH, Bekermeier M. A new way to look at atherosclerotic involvement of the artery wall and the functional effects. Annals of the New York Academy of Sciences. 454: 9-22. PMID 3907471 DOI: 10.1111/J.1749-6632.1985.Tb11840.X  0.01
1985 Davis HR, Glagov S, Zarins CK. Macrophages in human atherosclerosis: Role in the determination of plaque evolution Federation Proceedings. 44.  0.01
1984 Davis HR, Wissler RW. Apoprotein B quantification in rhesus and cynomolgus monkey atherosclerotic lesions. Atherosclerosis. 50: 241-52. PMID 6712774 DOI: 10.1016/0021-9150(84)90072-8  0.01
1984 Davis HR, Vesselinovitch D, Wissler RW. Reticuloendothelial system response to hyperlipidemia in rhesus and cynomolgus monkeys. Journal of Leukocyte Biology. 36: 63-80. PMID 6588132 DOI: 10.1002/Jlb.36.1.63  0.01
1984 Davis HR, Vesselinovitch D, Wissler RW. Histochemical detection and quantification of macrophages in rhesus and cynomolgus monkey atherosclerotic lesions. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 32: 1319-27. PMID 6501864 DOI: 10.1177/32.12.6501864  0.01
1984 Davis HR, Runyon-Hass A, Zarins CK, Glagov S. Interactive arterial effects of hypertension and hyperlipidemia Federation Proceedings. 43.  0.01
1983 Hass AJ, Davis HR, Elner VM, Glagov S. Identification of macrophages in sections of rabbit lung using acetoacetylated lipoproteins Journal of Histochemistry and Cytochemistry. 31: 1136-1138. PMID 6688438  0.01
1983 Elner VM, Hass AJ, Davis HR, Glagov S. An avidin-biotin-peroxidase method for Fc receptors on macrophages isolated from and in sections of rat lung Journal of Histochemistry and Cytochemistry. 31: 1139-1141. PMID 6224844  0.01
1981 Davis HR. Development of a high-speed patterning system for a narrow fabric weaving machine 0.01
1980 Backer TE, Attkisson CC, Barry JR, Brock TC, Davis HR, Kiresuk TJ, Kirkhart KE, Perloff R, Windle C. Information resources for program evaluators. Evaluation and Program Planning. 3: 25-33. PMID 10297948 DOI: 10.1016/0149-7189(80)90004-X  0.01
1980 Tze WJ, Tai J, Wong FC, Davis HR. Studies with implantable artificial capillary units containing rat islets on diabetic dogs Diabetologia. 19: 541-545. PMID 6780399 DOI: 10.1007/BF00253182  0.01
1978 Davis HR. Management of innovation and change in mental health sevices Hospital and Community Psychiatry. 29: 649-658. PMID 689592  0.01
1978 Davis HR, Salasin SE. Applied social research International Journal of Comparative Sociology. 19: 107-113. DOI: 10.1163/156854278X00194  0.01
1978 Davis HR. Laminar mass transfer from porous tubes and flat plates with wall resistance Applied Scientific Research. 34: 127-143. DOI: 10.1007/BF00418861  0.01
1977 Davis HR, Windle C, Sharfstein SS. Developing guidelines for program evaluation capability in community mental health centers Evaluation. 4: 25-29. PMID 10306207  0.01
1970 Davis HR, Parkinson GV. Mass transfer from small capillaries with wall resistance in the laminar flow regime Applied Scientific Research. 22: 20-30. DOI: 10.1007/BF00400512  0.01
1965 Holmes RR, Bayer RP, Errede LA, Davis HR, Wiesenfeld AW, Bergman PM, Nicholas DL. Studies on nitroso compounds. II. Dimerization of 4-substituted 2,6-dichloronitrosobenzenes. An equilibrium controlled by the resonance effect of para substituents Journal of Organic Chemistry. 30: 3837-3840.  0.01
1963 LUCERO RJ, BROWN BW, DAVIS HR. Seasonal variation in aberrant group behavior The Journal-Lancet. 83: 153-156. PMID 13931444  0.01
1963 Errede LA, Davis HR. The anomalous behavior of m-trifluoromethylnitrosobenzene dimer Journal of Organic Chemistry. 28: 1430-1431.  0.01
1962 Davis HR. Organization and supervision of student teaching in home economics education in off-campus centers Journal of Educational Research. 55: 578-581. DOI: 10.1080/00220671.1962.10882873  0.01
1955 DAVIS HR. Root pain from cervical osteoarthritis simulating angina pectoris Canadian Medical Association Journal. 72: 520. PMID 14364390  0.01
1950 Smith LI, Davis HR. Cyclopropanes. IV. Attempted synthesis of a nitrocyclopropyl sulfone (1) Journal of Organic Chemistry. 15: 824-831.  0.01
1950 Smith LI, Davis HR, Sogn AW. The reaction between quinones and metallic enolates. XXIV. Synthesis and reactions of bis-(2,4,5-trimethylquinonyl)-methane Journal of the American Chemical Society. 72: 3651-3655.  0.01
1944 Frank RL, Davis HR, Drake SS, Mcpherson JB. Ester interchange by means of the Grignard complex Journal of the American Chemical Society. 66: 1509-1510.  0.01
Show low-probability matches.